Advanced search
Publication Cover
Expert Review of Vaccines Volume 7, 2008 - Issue 2
Submit an article Journal homepage
99
Views
14
CrossRef citations to date
0
Altmetric
Review

Therapeutic vaccines against IgE-mediated allergies

Lars Hellman Department of Cell and Molecular Biology, BMC, Box 596, 751 24 Uppsala, Sweden. [email protected]
Pages 193-208 | Published online: 09 Jan 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Irene Meester & Juan Manuel Solis-Soto. (2009) Cytokines: monitors of disease severity for the clinic. Expert Opinion on Medical Diagnostics 3:2, pages 143-155.
Read now

Articles from other publishers (13)

Zhirong Fu, Srinivas Akula, Michael Thorpe & Lars Hellman. (2019) Highly Selective Cleavage of TH2-Promoting Cytokines by the Human and the Mouse Mast Cell Tryptases, Indicating a Potent Negative Feedback Loop on TH2 Immunity. International Journal of Molecular Sciences 20:20, pages 5147.
Crossref
Lars Torkel Hellman, Srinivas Akula, Michael Thorpe & Zhirong Fu. (2017) Tracing the Origins of IgE, Mast Cells, and Allergies by Studies of Wild Animals. Frontiers in Immunology 8.
Crossref
Falk Saupe, Matthias Reichel, Elisabeth J. M. Huijbers, Julia Femel, Per-Olof Markgren, C. Evalena Andersson, Sebastian Deindl, U. Helena Danielson, Lars T. Hellman & Anna-Karin Olsson. (2016) Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously. The FASEB Journal 31:3, pages 1204-1214.
Crossref
Risini D. Weeratna, Ghania Chikh, Lu Zhang, James D. Fraser, Jennifer M. Thorn, James R. Merson, Michael J. McCluskie, Brian R. Champion & Heather L. Davis. (2016) Immunogenicity of a peptide‐based anti‐IgE conjugate vaccine in non‐human primates. Immunity, Inflammation and Disease 4:2, pages 135-147.
Crossref
Falk Saupe, Elisabeth J. M. Huijbers, Tobias Hein, Julia Femel, Jessica Cedervall, Anna-Karin Olsson & Lars Hellman. (2015) Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters. The FASEB Journal 29:8, pages 3253-3262.
Crossref
Ying Lei, Vamsi Boinapally, Anna Zoltowska, Mikael Adner, Lars Hellman & Gunnar Nilsson. (2015) Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma. PLOS ONE 10:7, pages e0133774.
Crossref
Julia Femel, Elisabeth J.M. Huijbers, Falk Saupe, Jessica Cedervall, Lei Zhang, Pernilla Roswall, Erik Larsson, Helena Olofsson, Kristian Pietras, Anna Dimberg, Lars Hellman & Anna-Karin Olsson. (2014) Therapeutic vaccination against fibronectin ED-A attenuates progression of metastatic breast cancer. Oncotarget 5:23, pages 12418-12427.
Crossref
Anna-Karin Olsson. (2014) Therapeutic vaccination targeting the tumour vasculature. Biochemical Society Transactions 42:6, pages 1653-1657.
Crossref
Elisabeth J.M. Huijbers, Julia Femel, Karl Andersson, Hanna Björkelund, Lars Hellman & Anna-Karin Olsson. (2012) The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B—a prerequisite for clinical development. Vaccine 30:2, pages 225-230.
Crossref
Elisabeth J. M. Huijbers, Maria Ringvall, Julia Femel, Sebastian Kalamajski, Agneta Lukinius, Magnus Åbrink, Lars Hellman & Anna‐Karin Olsson. (2010) Vaccination against the extra domain‐B of fibronectin as a novel tumor therapy. The FASEB Journal 24:11, pages 4535-4544.
Crossref
Alexander Link & Martin F Bachmann. (2010) Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines. Immunotherapy 2:4, pages 561-574.
Crossref
Maria Ringvall, Elisabeth J.M. Huijbers, Parvin Ahooghalandari, Ludmila Alekseeva, Tatyana Andronova, Anna-Karin Olsson & Lars Hellman. (2009) Identification of potent biodegradable adjuvants that efficiently break self-tolerance—A key issue in the development of therapeutic vaccines. Vaccine 28:1, pages 48-52.
Crossref
Bruce Hammerberg. (2009) Canine immunoglobulin E. Veterinary Immunology and Immunopathology 132:1, pages 7-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.